| Maraviroc for previously treated patients with R5 HIV-1 infection RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ... New England Journal of Medicine 359 (14), 1429-1441, 2008 | 965 | 2008 |
| HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk … S Serrano-Villar, T Sainz, SA Lee, PW Hunt, E Sinclair, BL Shacklett, ... PLoS pathogens 10 (5), e1004078, 2014 | 751 | 2014 |
| Tuberculous meningitis in patients infected with the human immunodeficiency virus J Berenguer, S Moreno, F Laguna, T Vicente, M Adrados, A Ortega, ... New England Journal of Medicine 326 (10), 668-672, 1992 | 646 | 1992 |
| Towards an HIV cure: a global scientific strategy Nature reviews Immunology 12 (8), 607-614, 2012 | 632 | 2012 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 486 | 2010 |
| Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ... The Journal of infectious diseases 210 (3), 354-362, 2014 | 468 | 2014 |
| Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ... The lancet HIV 7 (8), e554-e564, 2020 | 467 | 2020 |
| Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study J Del Amo, R Polo, S Moreno, A Díaz, E Martínez, JR Arribas, I Jarrín, ... Annals of internal medicine 173 (7), 536-541, 2020 | 435 | 2020 |
| Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study … A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ... PLoS medicine 10 (9), e1001510, 2013 | 427 | 2013 |
| The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. M Ray, R Logan, JAC Sterne, S Hernández-Díaz, JM Robins, C Sabin, ... AIDS (London, England) 24 (1), 123-137, 2010 | 421 | 2010 |
| Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel V Soriano, M Sulkowski, C Bergin, A Hatzakis, P Cacoub, C Katlama, ... Aids 16 (6), 813-828, 2002 | 405 | 2002 |
| When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study HIV-CAUSAL Collaboration* Annals of internal medicine 154 (8), 509-515, 2011 | 364 | 2011 |
| Linezolid for the treatment of multidrug-resistant tuberculosis J Fortun, P Martín-Dávila, E Navas, MJ Pérez-Elías, J Cobo, M Tato, ... Journal of Antimicrobial Chemotherapy 56 (1), 180-185, 2005 | 340 | 2005 |
| Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals JF Vázquez-Castellanos, S Serrano-Villar, A Latorre, A Artacho, ... Mucosal immunology 8 (4), 760-772, 2015 | 335 | 2015 |
| Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: a comparative study V PINTADO, P Martin-Rabadan, ML RIVERA, S MORENO, E BOUZA Medicine 80 (1), 54-73, 2001 | 325 | 2001 |
| Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study L Martín-Carbonero, Y Benhamou, M Puoti, J Berenguer, J Mallolas, ... Clinical Infectious Diseases 38 (1), 128-133, 2004 | 321 | 2004 |
| Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis J González-Martín, JM García-García, L Anibarro, R Vidal, J Esteban, ... Enfermedades Infecciosas y Microbiología Clínica 28 (5), 297. e1-297. e20, 2010 | 314 | 2010 |
| Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy C Gutiérrez, S Serrano-Villar, N Madrid-Elena, MJ Pérez-Elías, ME Martín, ... Aids 30 (9), 1385-1392, 2016 | 275 | 2016 |
| Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio S Serrano-Villar, MJ Pérez-Elías, F Dronda, JL Casado, A Moreno, ... PloS one 9 (1), e85798, 2014 | 275 | 2014 |
| Risk for developing tuberculosis among anergic patients infected with HIV S Moreno, J Baraia-Etxaburu, E Bouza, F Parras, M Perez-Tascon, ... Annals of internal medicine 119 (3), 194-198, 1993 | 255 | 1993 |
